Clinical Trial

The AMARA (As Much As Reasonably Achievable) Study

Recruiting
View on ClinicalTrials.gov →
Summary
Subjects with large inoperable liver tumors defined as at least 1 lesion larger than 5cm in maximum diameter. For the purposes of the present study, we define the AMARA principle in intensified regional TARE as a planned irradiated tumor dose \>200Gy by the partition model. The purpose of the study is to evaluate the safety and efficacy of Y90 high dose radioembolization for the management of large inoperable liver tumors. In addition, to correlate the safety and efficacy with the post-treatment dosimetry analysis (by MIM Software Inc) based on 90Y-PET/CT imaging.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-05.
Trial Details
NCT Number NCT06257030
Lead Sponsor University Hospital of Patras
Conditions Liver Cancer
Enrollment 100 participants
Start Date 2024-02-05
Primary Completion 2027-02-05 (estimated)
Study Completion 2027-02-05 (estimated)
Updated on ClinicalTrials.gov 2024-04-24